Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

George Washington University (GW)

Status: Terminated

Conditions: Central Serous Chorioretinopathy

Treatments: Device: Micropulse Laser Treatment; Other: No treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT01982383

021236

Details and patient eligibility

About

The investigators hypothesis is that using the micropulse laser in patient with Central Serous Chorioretinopathy (CSC) will prompt resolution of CSC and will be effective in significantly minimizing visual recovery time from this disease as well as potentially preventing recurrences.

Full description

The investigators hypothesize that application of 577nm micropulse laser in patients with CSC will prompt resolution of CSC as measured by ocular coherence tomography and best corrected visual acuity. This will be a pilot study to establish sound methods and provide some insights to the safety and efficacy of CSC treatment.

Enrollment: 2 patients

Sex: All

Ages: 30 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with new diagnosis of CSC and no other comorbidities or prior retinal treatment
• Patients ranging from 30 to 60 years of age

Exclusion criteria

• Patients with no case of CSC
• Patients with other macular comorbidities including but not limited to diabetic retinopathy, macular degeneration
• Patients with prior retinal treatment

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

2 participants in 2 patient groups, including a placebo group

Micropulse Laser Treatment

Experimental group

Description:

Patient's randomized to ML treatment would be treated with the following settings: 200 micron spot size, 0.2 second duration, 15% duty cycle, and 300 milliWatt power. Their eyes would be dilated prior to treatment with standard mydriatic medications, including Tropicamide and Phenylephrine

Treatment:

Device: Micropulse Laser Treatment

No Treatment

Placebo Comparator group

Description:

Patients randomized to this treatment arm, will not receive treatment for CSC. They will continue to be observed at month 1 and month 3. If any worsening of pathology is found during the follow up visits, the patient will be removed from the study and given appropriate standard of care by the attending

Treatment:

Other: No treatment